GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Inventories, Raw Materials & Components

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Inventories, Raw Materials & Components : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Inventories, Raw Materials & Components?

Telomir Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Mar. 2024 was $0.00 Mil.


Telomir Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Telomir Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Inventories, Raw Materials & Components Chart

Telomir Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
- - -

Telomir Pharmaceuticals Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only - - - - -

Telomir Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines